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Art materials are used by individuals of all ages, ranging from kindergarten children to adults studying 
the arts at a university level, as well as the general public, senior citizens, and mentally compromised 
individuals. Art materials have the potential of containing toxic materials, including carcinogens 
(such as nickel, chromium, cadmium, and lead) and reproductive toxins in their formulations. These 
toxic chemicals can be present as a result of intentional addition or contaminants. Such occurrences 
are expected to be higher in products manufactured in countries where product safety laws are less 
strict or not properly enforced.
Exposure to carcinogenic chemicals causes DNA damage leading to mutations that can activate 
oncogenes or inactivate antioncogenes, thus, predisposing cells to oncogenesis. Importantly, the 
heavy metals, such as nickel, can also dysregulate homologous DNA recombination (HR) (1). 
Although HR in normal cells is the most precise DNA repair mechanism and plays a vital role in the 
maintenance of genomic integrity, its dysregulation can induce genomic instability (2, 3), which is 
associated with progression in cancer (2). Data from our laboratory also show that exposure to nickel 
is associated with induction of a panel of HR genes, including (RAD51, RAD51 paralogs, RAD50, 
and RAD23) as well as leads to increased HR activity, genomic instability, and development of drug 
resistance in cancer (myeloma) cells (2).
Toxic metals (such as nickel, copper, mercury, and lead) also induce breaks in DNA. Exposure 
to such chemicals even at low doses can be risky because their genotoxic effect can potentially be 
increased by their interactions with each other and/or with other environmental or genetic factors. 
It has been demonstrated that simultaneous exposure to more than one heavy metals is associated 
with increased toxicity, relative to that observed following exposure to single metal (4). Toxicity of 
these compounds can also be increased in the presence of X-rays. A model proposed by Hengstler 
et al. (5) suggests that simultaneous exposure to multiple metals can lead to several fold increase 
in the toxicity relative to that induced by single compound. We, therefore, believe that constant 
exposure to material containing such chemicals can potentially increase cancer risk, especially in 
the individuals with genetic and/or other susceptibilities, including those related to certain lifestyles 
(6). Consistently, the reports suggest that there is an increased incidence of death due to cancers of 
various organs in artists (7, 8).
Art Materials that do contain toxic materials can have serious adverse health effects among users, 
especially small children and those with mental health issues. To minimize such effects, the US 
Government has enacted certain product safety laws and regulations. One of those regulations is 
the Federal Hazardous Substances Act (FHSA), which is being implemented by the US Consumer 
Product Safety Commission (CPSC). One of the components of the FHSA is “Labeling of Hazardous 
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Art Materials Act (LHAMA).” This section deals with toxicologi-
cal reviews of Art Material formulations for chronic toxicity and 
proper labeling.
Labeling of Hazardous Art Materials Act requires that all 
art materials offered for sale to consumers of all ages in the US 
must undergo a toxicological review by a qualified toxicologist 
such as Diplomate American Board of Toxicology (DABT) 
of the complete formulation of each product to determine the 
product’s potential for producing adverse chronic health effects; 
in addition, the art materials be properly labeled for acute and 
chronic hazards, as required by the LHAMA (9) and the FHSA 
(10), respectively.
An “art material” or “art material product” means any substance 
marketed or represented by the producer or repackager as suitable 
for use in any phase of the creation of any work of visual or graphic 
art of any medium and packaged in sizes intended for individual 
users of any age or those participating in a small group (11).
After toxicological reviews have been conducted for chronic 
hazards on art material formulations, the qualified toxicologists 
then recommend appropriate statements for art materials and 
also recommend a conformance statement. The conformance 
statement can read: “Conforms to ASTM Practice D-4236”; 
“Conforms to ASTM D-4236”; or “Conforms to the health 
requirements of ASTM D-4236.” According to the regulation at 16 
C.F.R. § 1500.14(b) (8) (i) (C) (6), these toxicological reviews are 
valid for the period of 5 years only. The regulation states: “[T]he 
producer or repackager shall have a toxicologist review as neces-
sary, but at least every 5 years, art material product formulation(s) 
and associated label(s) based upon the then-current, generally 
accepted, well-established scientific knowledge.”
Based on our long-term experience in the field, we have come 
to realize that it is impossible for the consumers to fully benefit 
from the 5-year re-review requirement; this is because either most 
consumers are unaware of 5-year re-reviewing requirement or they 
have no practical means to verify that the 5-year expiry period has 
already expired. Verification is only possible when the expiry date of 
the toxicological review or the date of toxicological review is marked 
on the Art Material label. This practice is also expected to help CPSC 
inspector assure compliance to 5-year re-review requirement.
In the absence of expiry dates of the toxicological reviews, 
it is impossible for consumers to know if the art materials they 
buy and use are still in compliance with the Federal regulation 
and are in fact safe based on the current generally accepted, well-
established scientific knowledge. Therefore, we suggest that the 
CPSC amends the LHAMA and incorporates the requirement of 
adding the dates toxicological reviews are conducted or the dates 
toxicological reviews will expire.
This amendment will be in line with Section 103 of the 
CPSIA entitled “Tracking Labels for Children’s Products” (12) 
and Tracking Label Requirement for Children’s Products (12) 
that mandate, in pertinent part, “distinguishing marks” on all 
children’s products and their packaging to enable the manufac-
turer and the ultimate purchaser to “ascertain” certain source 
and production information. These markings are to enable the 
manufacturer, retailers, and the ultimate consumer to ascertain 
the manufacturer or private labeler, location and date of produc-
tion of the product, and cohort information (batch, run number, 
or other identifying characteristic). These new requirements 
become effective on August 14, 2009.
We believe that this practice will not only remove hundreds 
of non-compliant Art Materials out of the US market especially 
those imported from other countries, but will also protect US 
consumers, especially children, mentally compromised individu-
als, and the elderly from unchecked chronically toxic chemicals, 
including carcinogens and reproductive toxins.
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